Look For Institutional Buying In Intellia Therapeutics Inc (NASDAQ: NTLA)
Intellia Therapeutics Inc (NTLA) concluded trading on Wednesday at a closing price of $8.87, with 4.22 million shares of worth about $37.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -44.39% during that period and on April 30, 2025 the price saw a […]
Why Should You Put Intellia Therapeutics Inc (NASDAQ: NTLA) On Your Portfolio?
Currently, there are 102.03M common shares owned by the public and among those 97.42M shares have been available to trade. The company’s stock has a 5-day price change of -23.77% and -44.40% over the past three months. NTLA shares are trading -42.92% year to date (YTD), with the 12-month market performance down to -75.81% lower. […]
An Important Check-Up On Intellia Therapeutics Inc (NASDAQ: NTLA)
Intellia Therapeutics Inc (NTLA) concluded trading on Wednesday at a closing price of $8.31, with 4.15 million shares of worth about $34.47 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.28% during that period and on March 26, 2025 the price saw a […]
Growth Story Still Intact For Intellia Therapeutics Inc (NTLA)
Intellia Therapeutics Inc (NTLA) concluded trading on Thursday at a closing price of $8.70, with 3.59 million shares of worth about $31.22 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.42% during that period and on March 20, 2025 the price saw a […]
An Important Check-Up On Intellia Therapeutics Inc (NASDAQ: NTLA)
Intellia Therapeutics Inc (NTLA) concluded trading on Thursday at a closing price of $9.90, with 4.49 million shares of worth about $44.41 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -54.21% during that period and on March 06, 2025 the price saw a […]
